Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ipca Laboratories Ltd. Capital/Financing Update 2024

Oct 24, 2024

61700_rns_2024-10-24_1d18ed90-4fa7-4965-9add-87d46bf52b67.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

October 24, 2024

==> picture [105 x 47] intentionally omitted <==

THRU ONLINE FILING

BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 023 Scrip Code : 524494

National Stock Exchange India Limited Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra – (East) Mumbai-400051 Scrip Code : IPCALAB

Dear Sirs,

Pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, 14[th] November, 2024, inter-alia,

  1. To consider and take on record the Standalone and Consolidated Unaudited Financial Results for the 2[nd] quarter and half year ended 30[th] September, 2024; and

  2. To consider declaration of Interim Dividend for the financial year 2024-25.

We further wish to inform you that the Company has decided to fix Friday, 22[nd] November, 2024 as the ‘Record Date’ for the Members entitlement of interim dividend for the financial year 2024-25 that may be declared at the said Board Meeting on 14[th] November, 2024.

Further, with reference to the above meeting of the Board of Directors, we have already informed vide our letter dated 23[rd] September, 2024 that the trading window for dealing in the securities of the Company by the Insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed with immediate effect and until 48 hours after the declaration of the Company’s unaudited financial results for the 2[nd] quarter and half year ended 30[th] September, 2024 of the financial year 2024-25, i.e., till 16[th] November, 2024.

Thanking you

Yours faithfully For Ipca Laboratories Limited

Digitally signed by Harish Pandurang Kamath DN: c=IN, o=Personal, title=1715, Harish Pandurang pseudonym=585f434c9c014c338904fe5f4cd8762a, 2.5.4.20=955479ec580ea690ffd8de8b74071cf6f1ee247da687a7ae8 Kamath 2030a7ae82c443b, postalCode=400063, st=Maharashtra, serialNumber=72050fb9fadcbc5de6404685117b8355792f5784c7617d9c4cae2a3887d6b809, cn=Harish Pandurang Kamath Date: 2024.10.24 12:31:24 +05'30' Harish P. Kamath Corporate Counsel & Company Secretary (ACS 6792)

==> picture [445 x 70] intentionally omitted <==